Latham & Watkins
VC Fund
Los Angeles, United States
Latham & Watkins is a VC fund in Los Angeles focused on SaaS and Biopharma. Latham & Watkins offers legal advisory services. The firms practice areas include antitrust, joint ventures and strategic alliances, entertainment and media industry, funds and acquisition vehicles, finance, hotels, resorts, and gaming, out-of-court restructurings, benefits and compensation, controversy practice, exempt organizations, andinternational tax. Latham & Watkins was founded in 1934 and is headquartered in Los Angeles, California. The firm has additional offices in Boston, Chicago, Frankfurt, Hamburg, Hong Kong, London, Moscow, New Jersey, and New York.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Latham & Watkins invests in
Stages Latham & Watkins invests in
Countries Latham & Watkins invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adrian Davis
|
|||
Alfred Harutunian
|
|||
Colin Stretch
|
|||
Thomas Forschbach
|
|||
Eric Schwartzman
|
|||
| See all 10 contacts → | |||
Investment Focus
Industry
- SaaS 2 (40%)
- Biopharma 2 (40%)
- Water 1 (20%)
- Medical 1 (20%)
- Big Data 1 (20%)
Stage
- Seed 2 (40%)
- Series A 1 (20%)
- Series D 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- United States 3 (60%)
- United Kingdom 1 (20%)
- The Netherlands 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Adrian Davis
Chief Attorney Development and Knowledge Officer
|
Chief Attorney Development and Knowledge Officer | Total investments: 0 | Find email | |
|
Alfred Harutunian
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Colin Stretch
Of Counsel
|
Of Counsel | Total investments: 1 | Find email | |
|
Thomas Forschbach
Partner
|
Partner | Total investments: 0 | Find email | |
|
Eric Schwartzman
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DealStack
|
Helping Private Equity dealmaking evolve. | $5.5M / Seed / Apr 08, 2025 | |
Network Bio
|
Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M / Seed / Feb 27, 2025 | |
Reynen Court
|
Reynen Court enables law firms and corporate legal departments to speed their adoption of AI and other new technologies. Its platform combines a solution store for legal technology with a powerful control panel that makes it easy to adapt and manage modern cloud-based software applications without having to trust firm or client content to therapidly growing universe of vertically integrated SaaS providers. The platform also lets firms manage subscriptions and provisioning from one place and provides valuable telemetry and enhanced interoperability between and among third-party applications.It was founded in 2018 and is headquartered in Amsterdam. | $4.3M / Venture - Series Unknown / Mar 08, 2022 | |
DrizzleX
|
DrizzleX is an IoT-based SaaS platform that reduces water use in apartment buildings by 20-40% or more. Our proprietary IoT micrometers combined with our powerful SaaS dashboard provides customers with real-time actionable information so that they can pinpoint and fix leaks and encourage tenants to conserve water. No other solution is as costeffective, easy to install in any apartment building, and operates reliably for years with zero maintenance. | $1M / Series A / Nov 01, 2020 | |
Kythera Biopharmaceuticals
|
KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasingdiscretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market. | $37.4M / Series D / Sep 19, 2011 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Latham & Watkins invest in?
Latham & Watkins invests primarily in SaaS, Biopharma and Water startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Latham & Watkins?
Public channels for Latham & Watkins include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Latham & Watkins?
The team at Latham & Watkins includes Adrian Davis (Chief Attorney Development and Knowledge Officer), Alfred Harutunian (Chief Financial Officer) and Colin Stretch (Of Counsel), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
